Langerhans cells increase their expression of integrin αvβ8 through migration and are needed for Tregs induction by epicutaneous immunotherapy (EPIT) [PDF]
Vincent Dioszeghy +7 more
openalex +2 more sources
Eating away at food allergy. [PDF]
Fitness/endurance as an analogy to food desensitization. Both involve exposing the body to an activity initially poorly tolerated to gain capacity: In food treatments this is the capacity to eat more of the food and in exercise it is the capacity to exercise. When viewed as such it may not be surprising that with most currently available treatments the
Du YJ, Guo JC, Upton JEM.
europepmc +2 more sources
Safety of Viaskin Milk Epicutaneous Immunotherapy (EPIT) in IgE-Mediated Cow's Milk Allergy (CMA) in Children (MILES Study) [PDF]
Karine Rutault +9 more
openalex +2 more sources
Enhanced Efficacy and Confirmed Safety of a Two-Year Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin® Peanut: The Continuation of the Vipes Phase IIb Randomized Controlled Trial (RCT) [PDF]
Hugh A. Sampson +19 more
openalex +2 more sources
Epicutaneous immunotherapy for the treatment of peanut allergy. [PDF]
Abstract Peanut allergy treatment options remain limited, but novel approaches are being studied, including epicutaneous immunotherapy (EPIT). EPIT uses the cutaneous immune system to promote tolerance to food allergens. Viaskin™ Peanut, an approach to EPIT in late‐stage clinical development uses an occlusive patch with a condensation chamber that ...
Ravindran M +5 more
europepmc +2 more sources
A Streamlined Approach to Basophil Activation Testing for Longitudinal Characterization of Toddlers with Peanut Allergy During a Multi-Site Phase 3 Double-Blind Placebo-Controlled Trial of Epicutaneous Immunotherapy (EPIT) [PDF]
Alexander Grishin +7 more
openalex +2 more sources
Long-term Safety Results of Epicutaneous Immunotherapy (EPIT) with Viaskin Peanut in Peanut-Allergic Children Aged 4-11 Years in the Phase 3 PEOPLE Study [PDF]
David E. Fleischer +7 more
openalex +2 more sources
Efficacy and Safety of Long-Term Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin® peanut: Results of the Two-Year Extension of the Vipes Phase IIb Clinical Trial [PDF]
Wayne G. Shreffler +4 more
openalex +2 more sources
The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
In recent decades, a rapid increase in the prevalence of food allergies has led to extensive research on novel treatment strategies and their mechanisms.
Guirong Liu +4 more
doaj +1 more source
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis [PDF]
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated Food Allergy.
Dhami, Sangeeta +2 more
core +9 more sources

